Concepedia

Alison Joly

AJ

Statistics

Publications

22

Citations

3.6K

H-Index

20

Active since

1993

Affiliations

Exelixis (United States)(Current)

Carolina Veterinary Specialists

Vanderbilt University

University of East-West Medicine

Oregon Health & Science University

Alison Joly is an author at Exelixis (United States) specializing in life sciences, medicine, and signal transduction.

Publications per year

1993–2013

22

Publications

22

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

F. Michael Yakes, Jason Chen, Jenny Tan et al. · Molecular Cancer Therapeutics · 2011 · 1.3K citations · Full text

, , +17

CTGF Expression is Induced by TGF- β in Cardiac Fibroblasts and Cardiac Myocytes: a Potential Role in Heart Fibrosis

Michelle Chen, Andrew Lam, Judith A. Abraham et al. · Journal of Molecular and Cellular Cardiology · 2000 · 437 citations

, , +14

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases

Fawn Qian, Stefan Engst, Peiwen Yu et al. · Cancer Research · 2009 · 338 citations

, , +17

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation

Stephanie Meyer, N.Gail Kohler, Alison Joly · FEBS Letters · 1997 · 160 citations · Full text

, , +17

Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion

Nikki Cheng, Anna Chytil, Yu Shyr et al. · Molecular Cancer Research · 2008 · 158 citations · Full text

, , +17

1–5 of 22